Search results
Results from the WOW.Com Content Network
D5 1/2NS 5% dextrose in half amount of normal saline (0.45% w/v of NaCl). [10] D5LR (5% dextrose in lactated Ringer solution) D50 – 50% dextrose in water; The percentage is a mass concentration, so a 5% glucose/dextrose solution contains 50 g/L of glucose/dextrose (5 g per 100 ml).
dextrose 5% in lactated Ringer's solution (intravenous sugar solution) D5NS dextrose 5% in normal saline (0.9%) (intravenous sugar solution) D5W, D 5 W dextrose 5% in water (intravenous sugar solution) D10W, D 10 W dextrose 10% in water (intravenous sugar solution) da da: give DAW dispense as written (i.e., no generic substitution)
The United States Drug Enforcement Administration (DEA) maintains lists regarding the classification of illicit drugs (see DEA Schedules).It also maintains List I of chemicals and List II of chemicals, which contain chemicals that are used to manufacture the controlled substances/illicit drugs.
D50, an intravenous sugar solution of 50% dextrose; D50, the ICD-10 code for iron deficiency anemia; D50, the mass-median-diameter in particle-size distribution measurements, considered to be the average particle size by mass; D50 (film), working title for a Tamil-language film
Dextrose 5% and 10% come in IV bag and syringe form, and are mainly used in infants and to provide a fluid medium for medications. Dextrose 25% and 50% are heavily necrotic due to their hyperosmolarity, and should only be given through a patent IV line – any infiltration can cause massive tissue necrosis.
Dextrose [1] – same as glucose, dextrose is an alternative name of glucose; Disaccharide – also known as double sugar, it is made when two monosaccharides (aka simple sugars) are joined together. Examples include sucrose, lactose, and maltose. Evaporated cane juice [1]
Acarbose [1] [2] is an anti-diabetic drug used to treat diabetes mellitus type 2 and, in some countries, prediabetes.It is a generic sold in Europe and China as Glucobay (), in North America as Precose (Bayer Pharmaceuticals), and in Canada as Prandase ().
Lipinski's rule of five, also known as Pfizer's rule of five or simply the rule of five (RO5), is a rule of thumb to evaluate druglikeness or determine if a chemical compound with a certain pharmacological or biological activity has chemical properties and physical properties that would likely make it an orally active drug in humans.